cannabis dependence
Information
- Disease name
- cannabis dependence
- Disease ID
- DOID:1849
- Description
- "A drug dependence that involves the continued use of cannabis despite problems related to use of the substance." [url:http\://en.wikipedia.org/wiki/Cannabis_dependence]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT01031563 | Completed | Risk Perception in Drug-Dependent Adults With and Without Schizophrenia | August 18, 2009 | May 3, 2012 | |
| NCT00167297 | Completed | Phase 2 | Atomoxetine for the Treatment of Cannabis Dependence | November 2004 | July 2005 |
| NCT00350285 | Completed | Phase 2 | The Teen Marijuana Check-Up | September 2004 | June 2008 |
| NCT00395044 | Completed | Phase 2 | Gabapentin Treatment of Cannabis Dependence | August 2006 | July 2008 |
| NCT01639872 | Completed | Phase 4 | Clozapine for Cannabis Use in Schizophrenia | May 1, 2013 | March 29, 2017 |
| NCT01675661 | Completed | Phase 3 | Achieving Cannabis Cessation-Evaluating N-Acetylcysteine Treatment | January 2014 | August 2015 |
| NCT01697709 | Completed | Phase 2 | Quetiapine Pharmacotherapy for Cannabis Dependence | October 1, 2012 | April 30, 2017 |
| NCT01747850 | Completed | Phase 2 | Sativex and Behavioral-relapse Prevention Strategy in Cannabis Dependence | March 2013 | November 2015 |
| NCT01748799 | Completed | N/A | Fixed or Self-Titrated Dosages of Sativex on Cannabis Users | February 2013 | September 2014 |
| NCT01793961 | Completed | N/A | Effects of Chronic Intake of Cannabis on Contrast Sensitivity | March 22, 2013 | September 10, 2018 |
| NCT01834794 | Completed | N/A | Targeting Tobacco Cessation During Treatment for Cannabis Use Disorders | March 2013 | January 2015 |
| NCT01875796 | Completed | Phase 1 | Integrated CBT for Cannabis Dependence With Co-occurring Anxiety Disorders | June 2013 | |
| NCT02088177 | Completed | Phase 1/Phase 2 | Study of Long-Acting Injectable Naltrexone to Treat Cannabis Dependence | October 2014 | March 2016 |
| NCT02210195 | Completed | Phase 2 | Pharmacological Treatment of Comorbid Alcohol and Marijuana Withdrawal and Dependence | September 4, 2014 | December 19, 2016 |
| NCT02711371 | Completed | Social and Emotional Brain Function in Cannabis Users | July 2015 | December 2016 | |
| NCT02946489 | Completed | Phase 1 | Facilitating the Behavioral Treatment of Cannabis Use Disorder | October 2016 | August 2018 |
| NCT03104257 | Completed | The Neural Correlates of Cannabis Use | December 2016 | April 27, 2022 | |
| NCT03662529 | Completed | N/A | Neurobehavioral Measurement of Substance Users in Outpatient Treatment Setting | June 5, 2017 | February 1, 2018 |
| NCT04202146 | Completed | N/A | Cannabis Use and Relapse After One Week of Contingency Management Therapy | July 15, 2018 | September 15, 2019 |
| NCT04595318 | Completed | Phase 4 | Varenicline for Co-occurring Cannabis and Tobacco Use | January 2015 | July 2015 |
| NCT04851392 | Completed | N/A | Do Adolescents and Adults Differ in Their Acute Response to Cannabis? | March 11, 2019 | June 16, 2021 |
| NCT00542750 | Completed | Phase 1/Phase 2 | An Open-Label Trial of N-Acetylcysteine in Cannabis Dependent Adolescents | January 2008 | December 2008 |
| NCT00656487 | Completed | Phase 2 | Clinical and Neurobiological Effects of Cannabis Dependence in Young Adults | April 30, 2008 | January 6, 2011 |
| NCT00838448 | Completed | N/A | Interactions Between Physical Activity and Cannabis Use in Adults | January 2009 | June 2013 |
| NCT00954681 | Completed | Phase 2 | Study of Quetiapine Treatment for Cannabis Dependence | August 2009 | August 2010 |
| NCT00974376 | Completed | Phase 2 | Gabapentin Treatment of Cannabis Dependence | November 4, 2009 | May 19, 2016 |
| NCT01005810 | Completed | Phase 2 | A Trial of N-Acetylcysteine (an Over-the-Counter Medicine) in Adolescents Who Smoke Marijuana | September 2009 | August 2011 |
| NCT01020019 | Completed | Phase 2/Phase 3 | Combined Pharmacotherapy for Cannabis Dependency | January 2010 | September 2014 |
| NCT00114439 | Completed | Phase 2 | Lithium Cannabis Withdrawal Study | September 2005 | September 2006 |
| NCT01110434 | Completed | Phase 2 | Biobehavioral Effects of Topiramate on Cannabis-Related Outcomes in Adolescents | December 2009 | May 2012 |
| NCT01153490 | Completed | Phase 4 | Improving Substance Use and Clinical Outcomes in Heavy Cannabis Users With Quetiapine | October 22, 2010 | August 6, 2012 |
| NCT01204723 | Completed | Phase 1 | Medications Development for the Treatment of Cannabis Related Disorders | August 2009 | April 2012 |
| NCT01292642 | Completed | Phase 2 | Cognitive Behavioral Therapy and the Nicotine Transdermal Patch for Cannabis Dependence and Nicotine Dependence | August 2009 | June 2011 |
| NCT01347762 | Completed | Phase 2/Phase 3 | Nabilone for Cannabis Dependence: A Pilot Study | June 2010 | June 9, 2017 |
| NCT01467999 | Completed | Phase 1 | Open-Label Pilot Study of Guanfacine-Extended Release for the Treatment of Cannabis Dependence | February 2012 | October 2016 |
| NCT01603992 | Completed | Quiting Marijuana Use: Self-report Study of Quitting Straegies and Withdrawal Symptoms | November 8, 2005 | May 3, 2012 | |
| NCT01611948 | Completed | Phase 2 | Treatment for Cannabis Withdrawal and Dependence | May 2011 | October 2015 |
| NCT01618656 | Completed | Phase 2 | Safety and Efficacy of a FAAH-Inhibitor to Treat Cannabis Withdrawal | September 12, 2012 | March 11, 2016 |
| NCT06334016 | Not yet recruiting | Early Phase 1 | Evaluating the Delivery and Effects of THC Vaping Liquids in the Bloodstream | March 27, 2025 | March 1, 2028 |
| NCT05512091 | Not yet recruiting | Characterization of the Pattern of Consumption and Withdrawal Syndrome From Dual Cannabis and Tobacco Use | July 2023 | December 2025 | |
| NCT05445180 | Recruiting | N/A | Investigating the Neural Correlates of Cognitive Function in Psychosis Patients and Non-Psychiatric Controls With Cannabis Use | April 21, 2022 | May 2027 |
| NCT05620433 | Recruiting | N/A | Joint Effort 2.0: a Mobile Application With University Students | February 8, 2023 | January 2025 |
| NCT04721353 | Recruiting | Phase 4 | Reducing Cannabis Overuse With Prazosin | November 9, 2020 | June 30, 2025 |
| NCT05219825 | Recruiting | N/A | Breathwork-assisted Treatment for Cannabis Use Disorder | February 6, 2022 | August 2024 |
| NCT01730781 | Recruiting | Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning | July 2010 | December 2024 | |
| NCT01439828 | Terminated | Phase 2 | Clinical Trial of N-acetylcysteine Versus Placebo Efficacy in the Cannabis Withdrawal | February 2012 | February 2015 |
| NCT01598896 | Terminated | Phase 2/Phase 3 | Combination of Dronabinol and Clonidine for Cannabis Dependence in Patients With Schizophrenia | May 2012 | August 2017 |
| NCT01510015 | Unknown status | N/A | Evaluation of the Effects of Treatment of Psycho-stimulant and Cannabis-dependent Users in Israel | January 2012 | November 2013 |
| NCT01565174 | Unknown status | The Pharmaco-genetic and Brain Mechanisms Associated With Cannabis- Induced Psychosis | October 2012 | October 2014 | |
| NCT02801422 | Unknown status | Neural Indices Associated With Relapse in Cannabis Dependence | February 2016 | March 2019 | |
| NCT05434429 | Unknown status | N/A | Mobile Health for Problematic Behaviors and Substance Use | June 21, 2022 | February 2023 |
| NCT03221231 | Unknown status | Phase 4 | N-acetylcysteine for the Treatment of Cannabis Dependence: Working Mechanisms | May 15, 2016 | February 1, 2023 |
| NCT03366909 | Unknown status | N/A | Mindfulness Meditation and Cannabis Dependence : Therapy Effectiveness | May 1, 2018 | February 27, 2020 |
| NCT04513756 | Unknown status | N/A | Efficacy of Community Reinforcement Approach (CRA) in the Treatment of Cannabis Users | August 18, 2019 | December 21, 2021 |
| NCT00484367 | Unknown status | Phase 2/Phase 3 | A Comparison of Adolescent Group Therapy and Transitional Family Therapy for Adolescent Alcohol and Drug Abusers | July 1999 | August 2012 |
- Disase is a (Disease Ontology)
- DOID:9977
- Cross Reference ID (Disease Ontology)
- ICD10CM:F12.2
- Cross Reference ID (Disease Ontology)
- ICD9CM:304.3
- Cross Reference ID (Disease Ontology)
- MESH:D002189
- Cross Reference ID (Disease Ontology)
- NCI:C34445
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:268766005
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0006870